NEW YORK, Jan. 27, 2014 /PRNewswire/ -- Decision Resources Group finds the number of US consumers that are using their smartphones and tablets to search for prescription drug information is rising rapidly, according to data from ePharma Consumer® 2013, while searches through desktops and laptops is beginning to wane, reinforcing the need for prescription drug marketers to prioritize mobile investments. ePharma Consumer® helps marketers refine DTC multichannel planning based on patient behavioral insights.


Key Facts:

  • Among US consumers who own a smartphone and access prescription drug information online, 35 percent used their smartphone to research a prescription drug in 2013. That's up 52 percent over the 23 percent that did so in 2011.
  • More than a fifth of tablet-owning U.S. adults who look up prescription drug information online did so using their tablets in 2013 – almost triple the 8 percent that did so in 2011.
  • Prescription drug research through desktops and/or laptops dipped among owners of those devices that access prescription drug information online – 84 percent did so in 2013, down from 91 percent in 2011.
  • The use of mobile devices for research on prescription drugs varies by condition group. For example, more than half of smartphone-owning ADHD patients use these devices to search for prescription drug information online while 41 percent of smartphone-owners with multiple sclerosis did the same.


  • Rory Stanton, Consumer Insights Analyst, said: "Many brands have to act a lot faster when it comes to mobile optimization in 2014. Up to now, we mostly thought that poor mobile experiences were lost messaging opportunities, but new findings show that they could in fact hurt brand perception."
  • Monique Levy, Vice President, Research, said: "Our recent ePharma Competitive Analysis series of reports found that fewer than a third of product sites were mobile-optimized. It's not that marketers don't know that mobile optimization is important, but many challenges are getting in the way – such as deploying simultaneous website redesigns and establishing internal mobile guidelines and templates."

Additional Resources:

  • Decision Resources Group is offering a closed webinar on the new ePharma Consumer® study, which will present the latest research findings and takeaways. This webinar will take place February 14, 2014 at 2 pm Eastern and is open to clients of ePharma Consumer® 2013. Please contact us to learn how you can purchase this study and attend the webinar.

About ePharma Consumer® 2013
ePharma Consumer® is Manhattan Research's study and strategic advisory service focused on helping healthcare marketers understand how consumers are using digital channels for prescription drug information and services and how they are using pharma websites and online resources.  The study was fielded online in Q4 2013 among 6,605 U.S. adults, Segmented data is available for more than 50 patient audiences, including diagnosed patients, patients on therapy, caregivers and information seekers. Learn more here.

Key topics covered in the research include:

  • Technology profile
  • Benchmarking use, interest and attitudes towards pharma online assets
  • Mobile health
  • Social trends
  • Online health and pharma video
  • Patient support
  • Adherence
  • Pharma-provided tools

About the ePharma Competitive Analysis Series
The ePharma Competitive Analysis Series is Manhattan Research's new report series analyzing the state of pharmaceutical websites and branded online support programs. This report series aims to help brands design and implement competitive product websites, unbranded websites and online support programs.

In 2013, one hundred and sixty websites and support programs from more than 40 companies and 19 therapeutic categories are analyzed across multiple dimensions, including feature and function sets, audience targeting, and multi-channel integration. The series currently focuses on consumer digital assets in the US market, and will expand in 2014. Learn more here.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources Group

SOURCE Decision Resources Group

Germany and France Will See Strongest Growth in European Markets for Spinal Implants Through 2022

View Now